Gynecare submits ThermaChoice PMA data:
This article was originally published in Clinica
Executive Summary
Gynecare has submitted the results of a US clinical trial with its ThermaChoice uterine ablation system to the FDA as part of a PMA application. ThermaChoice is being investigated as an outpatient treatment for women with excessive menstrual bleeding (see Clinica No 725, p 14).